Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tiaoweichengqi Decoction (Tiao Wei Cheng Qi Tang) is a traditional Chinese medicine (TCM) formula traditionally used to treat "Yangming" stage heat patterns characterized by constipation and abdominal discomfort. In modern clinical research, it is being investigated for its potential to mitigate metabolic syndrome—including weight gain, dyslipidemia, and glucose intolerance—induced by the atypical antipsychotic olanzapine in patients with schizophrenia. The decoction typically comprises three primary ingredients: *Rheum palmatum* (Da Huang), *Glycyrrhiza uralensis* (Gan Cao), and *Natrii Sulfas* (Mang Xiao). Its mechanism in metabolic syndrome is thought to involve the regulation of gut microbiota, improvement of insulin sensitivity, and modulation of inflammatory pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tiao wei cheng qi tang.